Tags: Crohn’s diseaseIL10Inflammatory Bowel Diseasechronic kidney diseasekidney failure
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Emily Cooke Live Science Health reporter. London, United Kingdom | Argyria: The rare disease that turns people blue - about 2 months ago | |
| 2 | Nicoletta Lanese Live Science Science journalist. New York, USA | Gene variant guards against Parkinson's and could lead to therapies - about 1 year ago | |
| 3 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 4 | The Conversation Science Alert Science news. Official account. Australia | ||
| 5 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 6 | Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile | J&J’s growing rare disease focus brings a potential multi-use treatment to the table - 12 months ago The PharmaVoice 100: Rare disease warriors - over 1 year ago | |
| 7 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | AstraZeneca’s Rare Disease Pipeline Notches Another FDA Approval - 11 months ago | |
| 8 | Jason Mast STAT News Writing about science, medicine. | STAT+: Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases - 3 months ago STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire - 6 months ago STAT+: FDA rejects Rocket Pharmaceuticals’ gene therapy for ultra-rare condition, another setback for field - 8 months ago | |
| 9 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 10 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | 2024 PharmaVoice 100s: Rare Disease Warriors - 4 months ago |